Comprehensive Analysis of the Left Atrial Appendage Closure Device Market 2025-2034: Growth Rates, Trends, and Future Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the Left Atrial Appendage Closure Device market grown in recent years?
The market size of the left atrial appendage closure device has seen a fast-paced growth in the recent past. Its worth is expected to increase from $1.67 billion in 2024 to $2 billion in 2025, equivalent to a compound annual growth rate (CAGR) of 19.5%. The augment in the preceding times can be credited to the prevalence of atrial fibrillation, strategies devised for stroke prevention, clinical research and evidence, less invasive alternatives, the preference of patients for options which are non-pharmacological, the aging population, and the skilled training and expertise of physicians.
How is the left atrial appendage closure device market size expected to evolve during the forecast period?
In the coming years, the market for left atrial appendage closure devices is anticipated to undergo fast growth. It is projected to expand to $3.74 billion in 2029, with a compound annual growth rate (CAGR) of 17.0%. This predicted growth can be linked to the escalating global incidence of atrial fibrillation, emphasis on preventing strokes in high-risk individuals, increasing patient awareness, blending into standard clinical practices and worldwide initiatives in managing cardiovascular diseases. Emergence of percutaneous closure techniques, development in device designs, an increasing reliance on imaging technologies, concentration on minimally invasive procedures, and personalized device selection based on patient’s anatomy are among the key trends projected for the forecast period.
Get your left atrial appendage closure device market report here!
Which key drivers are propelling the left atrial appendage closure device market’s growth?
The increasing number of atrial fibrillation cases is anticipated to fuel the expansion of the left atrial appendage (LAA) closure device market. Atrial fibrillation, a health condition characterized by a typically quick and irregular heartbeat, happens when the atria, the heart’s upper chambers, don’t beat rhythmically or in sync. LAA closure devices are chiefly employed to treat atrial fibrillation, as they reduce stroke risk in patients with this type of cardiac arrhythmia and prevent blood clotting or escape. For instance, reports from the US-based government agency, the Centers for Disease Control and Prevention, in October 2022 stated that more than 454,000 hospital admissions annually in the US were predominantly due to atrial fibrillation. It is projected that by 2030, the number of atrial fibrillation patients in the US will be 12.1 million. Consequently, this escalating prevalence of atrial fibrillation is projected to drive the expansion of the left atrial appendage (LAA) closure device market. The progressive rise in the elderly population is anticipated to stimulate the growth of the left atrial appendage (LAA) closure device market. Individuals aged 65 or more fall under this elderly population bracket, which highlights their unique healthcare needs and age-related issues. LAA closure devices are advantageous for the elderly as they lessen the chances of a stroke connected with atrial fibrillation, which is a common issue among them. For instance, in August 2023, Eurostat, a Europe-based government agency, reported that in 2022, over 21% of the European Union population was 65 years old or older, with the median age being 44.4 years. This figure suggests that more than half of the European Union population has exceeded this age. Hence, this uptrend in the elderly population is propelling the left atrial appendage (LAA) closure device market growth.
What are the market segments in the left atrial appendage closure device industry?
The left atrial appendage closure device market covered in this report is segmented –
1) By Product: Epicardial Left Atrial Appendage (LAA) Devices, Endocardial Left Atrial Appendage (LAA) Devices
2) By Procedure: Percutaneous, Surgical
3) By End-User: Hospital, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Epicardial Left Atrial Appendage (LAA) Devices: Suture-Based Closure Devices, Ligation-Based Closure Devices, Clip-Based Closure Devices
2) By Endocardial Left Atrial Appendage (LAA) Devices: Plug-Based Closure Devices, Disc-Based Closure Devices, Mesh-Based Closure Devices
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13474&type=smp
Which leading companies are shaping the growth of the left atrial appendage closure device market?
Major companies operating in the left atrial appendage closure device market report are Johnson And Johnson Pvt Ltd., Abbott Laboratories, Medtronic plc., Atrium Medical Corporation, Boston Scientific Corporation, Gore Medical Inc., Lepu Medical Technology Co. Ltd., MicroPort Scientific Corporation, AtriCure Inc., Dune Medical Devices Ltd., Lifetech Scientific Corporation, Sahajanand Medical Technologies Limited, Occlutech, Cardiva Medical Inc., Sentreheart Inc., Aegis Medical Group, Coherex Medical Inc., EndoStim Inc., Conformal Medical Inc., Cardia Inc., Medical Device Business Service Inc., Protaryx Medical, Append Medical Ltd., Vascular Innovations Co. Ltd., Vivasure Medical Inc., Atritech Inc., CardiaMed AB, Cardialen Inc., Kalila Medical Inc.
What key trends are currently impacting the left atrial appendage closure device market’s development?
Main industry players in the left atrial appendage closure device market are introducing groundbreaking products such as Watchman FLX to enhance non-valvular atrial fibrillation (NVAF) treatment and present patients with a substitute to oral anticoagulation therapy. The Watchman FLX pro gadget is a self-expanding device inserted into the LAA to shut its entrance and deter blood clot formation. For example, in September 2022, Boston Scientific Corporation, a US establishment, gained endorsement for Watchman FLX from the Food and Drug Administration, an American federal entity, to lessen stroke likelihood in individuals with NVAF. This device is engineered to be more adaptable and easier to implant than former models of the Watchman device, enhancing its suitability for a more diverse patient population. Furthermore, it is a safety-proven and effective method to decrease NVAF-related stroke risks and serves as a beneficial option for those unable to undergo oral anticoagulation therapy or having issues controlling their oral anticoagulation therapy.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13474
Which geographic areas are influencing the growth of the left atrial appendage closure device market?
North America was the largest region in the left atrial appendage closure devices market in 2024. The regions covered in the left atrial appendage closure device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Ophthalmic Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/ophthalmic-devices-global-market-report
Patient Monitoring Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/patient-monitoring-devices-global-market-report
Peripheral Vascular Devices And Equipment Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
